BiomX (NYSEAMERICAN:PHGE – Get Free Report) is expected to be announcing its earnings results before the market opens on Tuesday, March 25th. Analysts expect the company to announce earnings of ($1.10) per share for the quarter.
BiomX Stock Up 1.9 %
PHGE stock opened at $0.64 on Monday. BiomX has a fifty-two week low of $0.48 and a fifty-two week high of $4.99. The firm has a market capitalization of $11.67 million, a P/E ratio of -0.20 and a beta of 1.27.
Wall Street Analysts Forecast Growth
Separately, HC Wainwright reissued a “buy” rating and issued a $2.00 target price on shares of BiomX in a report on Wednesday, January 8th.
BiomX Company Profile
BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).
See Also
- Five stocks we like better than BiomX
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- What is a Stock Market Index and How Do You Use Them?
- 3 ETFs to Ride the VIX Surge During Market Volatility
- Top Biotech Stocks: Exploring Innovation Opportunities
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for BiomX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BiomX and related companies with MarketBeat.com's FREE daily email newsletter.
